Evidence map›Paper›PMID 34873212›Full record

ArticleScientific reports2021

Effect of public corruption on the COVID-19 immunization progress.

Mohammad Reza Farzanegan, Hans Philipp Hofmann

Abstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mohammad Reza FarzaneganEconomics of the Middle East Research Group & School of Business and Economics, Center for Near and Middle Eastern Studies (CNMS), Philipps-Universität Marburg, Deutschhausstr. 12, 35037, Marburg, Germany. farzanegan@uni-marburg.de.
Hans Philipp HofmannEconomics of the Middle East Research Group & School of Business and Economics, Center for Near and Middle Eastern Studies (CNMS), Philipps-Universität Marburg, Deutschhausstr. 12, 35037, Marburg, Germany.

Funding

Deutscher Akademischer Austauschdienst 57571405
6 · The paper itself

Abstract

The coronavirus disease (COVID-19) outbreak has resulted in the death of over four million people since late 2019. To reduce the human and economic costs of COVID-19, different vaccines have been developed and distributed across countries. There has been significant cross-country variation in the vaccination of people against COVID-19. In this study, we focus on public corruption to explain the significant cause of cross-country variation in immunization progress. We suggest that countries with a higher degree of public corruption have been less successful in the vaccination of their population, controlling for other important determinants of immunization progress.

Indexed as

Public OpinionCOVID-19COVID-19 VaccinesDatabases, FactualHumansSARS-CoV-2VaccinationCOVID-19 Vaccines

Identifiers

PMID34873212
PMCPMC8648879

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.